Gandhi, O. H., Bryan, M. E., Pitoulias, M., Ince, W., Lee, S. M., Adamopoulou, E., Watson, R. A., Vavoulis, D., Schuh, A., Leung, C. S. K., Elliott, T., Lee, L. Y., Mair, R. (2026). Germline HLA class II diversity as a predictor of survival selectively in MHC-silenced gliomas.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2082